Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Apr 15;231(4):e697-e707.
doi: 10.1093/infdis/jiae633.

Molecular Epidemiology of Invasive Group B Streptococcus in South Africa, 2019-2020

Buhle Ntozini  1   2 , Sibongile Walaza  1   3 , Benjamin Metcalf  4 , Scott Hazelhurst  5   6 , Linda de Gouveia  1 , Susan Meiring  7 , Dineo Mogale  1 , Senzo Mtshali  8 , Arshad Ismail  8   9   10 , Kedibone Ndlangisa  1   2 , Mignon Du Plessis  1   2 , Vanessa Quan  7 , Sopio Chochua  4 , Lesley McGee  4 , Anne von Gottberg  1   2 , Nicole Wolter  1   2
Affiliations

Molecular Epidemiology of Invasive Group B Streptococcus in South Africa, 2019-2020

Buhle Ntozini et al. J Infect Dis. .

Abstract

Background: Group B Streptococcus (GBS) is a leading cause of neonatal meningitis and sepsis and an important cause of disease in adults. Capsular polysaccharide and protein-based GBS vaccines are currently under development.

Methods: Through national laboratory-based surveillance, invasive GBS isolates were collected from patients of all ages between 2019 and 2020. Phenotypic serotyping and antimicrobial susceptibility testing were conducted, followed by whole-genome sequencing for analysis of population structure and surface protein and resistance genes.

Results: In total, 1748 invasive GBS cases were reported. Of these, 661 isolates underwent characterization, with 658 yielding both phenotypic and genotypic results. Isolates (n = 658) belonged to 5 clonal complexes (CC1, CC8/10, CC17, CC19, and CC23) and 6 serotypes were detected: III (42.8%), Ia (27.9%), V (11.9%), II (8.4%), Ib (6.7%), and IV (2.3%). Phenotypically, only 1 isolate exhibited reduced penicillin susceptibility (minimum inhibitory concentration 0.25 µg/mL). Phenotypic resistance to erythromycin, clindamycin, and tetracycline was observed in 16.1%, 3.8%, and 91.5% of isolates, respectively. ermTR (34.9%) and mefA/E (30.1%) genes were most common among erythromycin-resistant isolates, while ermB predominated in clindamycin-resistant isolates (32.0%). tetM accounted for 95.8% of tetracycline resistance. All isolates carried at least 1 of the 3 pilus gene clusters, 1 of the 4 homologous alpha/Rib family determinants, and 98% harbored 1 of the serine-rich repeat protein genes. hvgA was found exclusively in CC17 isolates.

Conclusions: In our setting, β-lactam antibiotics remain appropriate for GBS treatment and polysaccharide and protein-based vaccines under development are expected to provide good coverage.

Keywords: Streptococcus agalactiae; antibiotic resistance; molecular characterization; population structure; vaccine targets.

PubMed Disclaimer

Conflict of interest statement

Potential conflicts of interest. S. M. has participated in an advisory board for GSK on meningococcal B vaccine use in South Africa, unrelated to this article. N. W. has received funding from Bill and Melinda Gates Foundation, World Health Organization, and Sanofi. A. v. G. is the chairperson of the National Advisory Group for Immunisation, South Africa. M. D. has received grant funding from the Bill and Melinda Gates Foundation. S. W. has received grant funding from the Bill and Melinda Gates Foundation, and the Centers for Diseases Control and Prevention. All other authors report no potential conflicts. All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed.

Figures

Graphical Abstract
Graphical Abstract
This graphical abstract is also available at Tidbit: https://tidbitapp.io/tidbits/molecular-epidemiology-of-invasive-group-b-streptococcus-in-south-africa-2019-2020-5b4cbbed-a52b-4ecd-a5e1-f977d9d47966?utm_campaign=tidbitlinkshare&utm_source=IO
Figure 1.
Figure 1.
Distribution of invasive group B Streptococcus serotypes by age group in South Africa, 2019–2020 (n = 656). Abbreviations: EOD, early-onset disease; LOD, late-onset disease.
Figure 2.
Figure 2.
A core SNP-based maximum likelihood phylogeny of 435 invasive GBS isolates collected from South African patients of all age groups from 2019 to 2020. Branch highlights in the tree represent CCs and the inner thin strip correspond to STs. The subsequent strips (from inner to outer strip) indicate age, province, serotype (Ia–V), PI determinants, alpha protein family determinants, SRR protein determinants, and the hypervirulent GBS adhesion (hvgA) protein. Noncolored branches represent singletons STs that to do not fall within a specific CC. The tree only included isolates that produced high-quality sequences with ≤ 150 contigs and N50 ≥ 30 000. Asterisks represent STs that could not be confidently assigned due to insufficient quality during base calling on 1 of the 7 housekeeping genes; however, the overall genome quality was good. Abbreviations: CC, clonal complex; EC, Eastern Cape; EOD, early-onset disease; FS, Free State; GA, Gauteng; GBS, group B Streptococcus; KZ, KwaZulu-Natal; LOD, late-onset disease; LP, Limpopo; MP, Mpumalanga; NC, Northern Cape; neg, negative; NW, North West; PI, pilus island; pos, positive; SNP, single-nucleotide polymorphism; SRR, serine-rich repeat; ST, sequence type; WC, Western Cape.
See this image and copyright information in PMC

References

    1. Madrid L, Seale AC, Kohli-Lynch M, et al. . Infant group B streptococcal disease incidence and serotypes worldwide: systematic review and meta-analyses. Clin Infect Dis 2017; 65(Suppl 2):S160–72. - PMC - PubMed
    1. Oddie S, Embleton ND. Risk factors for early onset neonatal group B streptococcal sepsis: case-control study. BMJ 2002; 325:308–11. - PMC - PubMed
    1. Lin F-YC, Weisman LE, Troendle J, Adams K. Prematurity is the major risk factor for late-onset group B Streptococcus disease. J Infect Dis 2003; 188:267–71. - PubMed
    1. Francois Watkins LK, McGee L, Schrag SJ, et al. . Epidemiology of invasive group B streptococcal infections among nonpregnant adults in the United States, 2008–2016. JAMA Intern Med 2019; 179:479–88. - PMC - PubMed
    1. Verani JR, McGee L, Schrag SJ.. Prevention of perinatal group B streptococcal disease: revised guidelines from CDC, 2010. MMWR Recomm Rep 2010; 59:1–36 - PubMed

MeSH terms

Substances